OKYO Pharma Limited (NASDAQ:OKYO)’s traded shares stood at 6.91 million during the latest session, with the company’s beta value hitting -0.03. At the last check today, the stock’s price was $0.97, to imply a decrease of -7.02% or -$0.07 in intraday trading. The OKYO share’s 52-week high remains $3.07, putting it -216.49% down since that peak but still an impressive 16.49% since price per share fell to its 52-week low of $0.81. The company has a valuation of $32.72M, with an average of 86000.0 shares in intraday trading volume over the past 10 days and average of 50.21K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for OKYO Pharma Limited (OKYO), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give OKYO a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
OKYO Pharma Limited (NASDAQ:OKYO) trade information
After registering a -7.02% downside in the latest session, OKYO Pharma Limited (OKYO) has traded red over the past five days. The 5-day price performance for the stock is -2.32%, and -28.37% over 30 days. With these gigs, the year-to-date price performance is -45.37%. Short interest in OKYO Pharma Limited (NASDAQ:OKYO) saw shorts transact 45397.0 shares and set a 1.21 days time to cover.
OKYO Pharma Limited (OKYO) estimates and forecasts
Looking at statistics comparing OKYO Pharma Limited share performance against respective industry, we note that the company has outperformed competitors. OKYO Pharma Limited (OKYO) shares are -34.66% down over the last 6 months, with its year-to-date growth rate higher than industry average at 33.33% against 18.60%.
OKYO Dividends
OKYO Pharma Limited has its next earnings report out in September. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
